Cipher Pharmaceuticals Inc
SWB:PHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cipher Pharmaceuticals Inc
SWB:PHE
|
CA |
|
L
|
L'Oreal SA
F:LOR
|
FR |
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
Bastide le Confort Medical SA
PAR:BLC
|
FR |
Wall St Price Targets
PHE Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for PHE is 12.61 EUR with a low forecast of 11.89 EUR and a high forecast of 13.96 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHE's stock price target?
Price Target
12.61
EUR
According to Wall Street analysts, the average 1-year price target for PHE is 12.61 EUR with a low forecast of 11.89 EUR and a high forecast of 13.96 EUR.
What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 1 year is 31%.
What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
-3%
The compound annual growth rate for Net Income over the next 3 years is -3%.
